The SITC Immune Monitor
August 2013

President's Message

Dear Colleagues,

The field of cancer research is thriving! New technologies are being implemented, treatment regimens are improving, drugs are being developed and immunotherapy is at the forefront of it all. This growth and progress in the field is clearly reflected in the record breaking number of abstracts submitted for the SITC 28th Annual Meeting. A total of 267 scientific abstracts were submitted, surpassing last year’s numbers by 23%. As a testament to SITC’s global reach, abstracts were submitted from 19 different countries. The high quality and the diversity of research displayed in this year’s submissions are an indication of the exciting advances currently taking place in the field and the ground breaking science you’ll see at the 2013 SITC Annual Meeting & Associated Programs to be held November 7-10.

In addition, SITC is also now accepting abstracts for the Workshop on Personalized Cancer Immunotherapy set to take place on Thursday, November 7, 2013. Both SITC members and nonmembers are encouraged to submit an abstract FREE of cost to be considered for one of the oral presentation slots during the program. Abstracts should focus on new, exciting data and provide solutions, or potential solutions, to important issues faced in the field of cancer immunotherapy today. Don’t miss this opportunity to share your research with the most influential scientists in the field. Submit your abstract today! For more information on SITC 2013, or to submit an abstract for the Workshop, please visit the SITC 2013 website.


Sincerely,


Francesco Marincola, MD
SITC President

Journal for ImmunoTherapy of Cancer (JITC)

Now Available - The Latest Issue of the Journal for ImmunoTherapy of Cancer

The July issue of the Journal for ImmunoTherapy of Cancer (JITC) is now available online. The issue, includes:

SITC is pleased to announce that the following two papers recently published in JITC have achieved 'highly accessed' status. SITC would like to congratulate the authors and all those who collaborated on these papers.

Officially launched in May, JITC is an online, peer-reviewed, open-access journal encompassing all aspects of tumor immunology and cancer immunotherapy, from basic research to clinical application. SITC is currently accepting submissions to JITC and invites everyone to submit your research to this highly accessed journal of your peers. As an added benefit of SITC membership, Society members will receive waived article processing charges through 2013!

"CURE...Yeah We Said It!"

Order Your SITC Cure T-shirt Today! 


Past  SITC President Bernie Fox, PhD sports his CURE t-shirt.

Show your support for cancer immunotherapy by purchasing a SITC "Cure...Yeah We Said It!" t-shirt, benefiting the SITC Forward Fund. T-shirts are $25 each including shipping (student rate is available; contact the SITC office for more details) and are available for purchase through the Forward Fund page on the SITC website.

The Forward Fund was established to create opportunities that advance the science, development and application of cancer immunotherapy, as well as help expand the knowledge of and interest in cancer immunotherapy as a fourth standard of care. The Fund endeavors to financially support early career scientists’ research initiatives as well as establish educational programs for stakeholders within and peripheral to the cancer immunotherapy field. Your contribution helps to insure the future of cancer immunotherapy research, translation, and clinical application.

Already have a SITC Cure t-shirt? Send us a picture of you wearing your CURE t-shirt and you could be featured in the next issue of The SITC Immune Monitor newsletter!

Melanoma Bridge 2013

SITC would like to invite you to join us at Melanoma Bridge 2013, to be held December 5-8, 2013 at the Royal Continental Hotel in Naples, Italy.

This scientific meeting aims at achieving a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and the biology of the cancer microenvironment. Melanoma Bridge 2013 is jointly organized by SITC, Istituto Nazionale Tumori Fondazione "G. Pascale,” Sidra Medical and Research Center, and Fondazione Melanoma Onlus.  The meeting will consist of the following sections:

  • Diagnosis and new procedures
  • Molecular advances and combination therapies
  • News in Immunotherapy
  • Tumor microenvironment and biomarkers
  • World-Wide Immunoscore Task Force update, followed by a Round Table of US and EU Regulatory Agency on Melanoma drugs.

New this year, Melanoma Bridge 2013 is also accepting abstracts for the presentation of posters. The deadline to submit an abstract is September 10, 2013, more details on abstract submission can be found at: http://www.melanomabridge.org/2013/call-for-abstract.php.

Meeting attendees are expected from all around the world and based on the success of the patients-experts meeting at last year’s Melanoma Bridge, representatives of melanoma patient associations are invited to join the event. For more information and to register, visit: http://www.melanomabridge.org/2013/registration_key_dates.php.

SITC 2013 Highlights


Housing Deadline – September 30, 2013

A limited block of hotel rooms have been reserved at the SITC 2013 meeting venue, the Gaylord National Hotel & Convention Center in National Harbor, MD. Housing reservations can be made up through September 30, but rooms fill up fast, so book today! Room rates established for the meeting will also be available for three days before and three days after the meeting dates, subject to availability.

A limited number of discounted rooms are also available for students/post-doctoral fellows. Contact the SITC office at 414-271-2456 for these rates.

For complete housing information, please visit the SITC 2013 website.

Early Registration Deadline – October 6, 2013

Discounts are available to delegates and guests that register for SITC 2013, before the October 6 early registration deadline. Take advantage of lower rates and register today.

SITC Annual Membership Business Meeting - November 7, 2013

All meeting attendees are invited to attend the SITC Annual Membership Business Meeting set to take place on Thursday, November 7 at 5:15 pm. The Membership Business Meeting will provide a review of the past year, along with a general update on the Society and its' initiatives moving forward.

NEW! SITC Annual Meeting Welcome Reception - November 7, 2013

New this year, immediately following the Membership Business Meeting, is the SITC Annual Meeting Welcome Reception from 6:00 – 7:30 pm. The reception, which includes an optional Speed Networking event, is a great way to reconnect with old friends and meet new acquaintances over cocktails before the SITC Annual Meeting begins. For more information or to register click here.

A Look At Membership

SITC Welcomes the 72 New Members Who Joined Last Month!

SITC now has representation from 34 countries around the world including a new member from Lebanon. Please consider referring a colleague to join our growing society. For more information about membership benefits, click here.

Reminder - Renew Your Membership & Cast Your Vote

Don’t forget to renew your membership! Leadership elections will take place in September and only current members are eligible to vote.

Thank You SITC Champions!

Thank you to all of our colleagues who serve as SITC Champions. The SITC Membership Save ChangesCommittee implemented the SITC Champion initiative to encourage two-way communication between the Society and institutions throughout the country. The goal of the SITC Champion program is to address the need for community education about immunotherapy, as well as disseminate information and build awareness for SITC’s educational programming and initiatives to institutions and companies across the globe. By becoming a SITC Champion, you will receive recognition from the Society and the cancer immunotherapy community, networking opportunities with other SITC Champions at top institutions, and the opportunity to further the field of cancer immunotherapy. To learn more about becoming a Champion, please contact SITC Membership & Outreach Director, Kate Flynn, MPA at kflynn@sitcancer.org or +1-414-271-2456.

 


Advertisement